← All trials
NCT07136545
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2025
- Primary completion
- Dec 31, 2026
- Completion date
- Dec 31, 2026
- First posted
- Aug 22, 2025
- Last posted
- Sep 10, 2025
- Enrollment
- 50
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Taipei Veteran General hospitalLead sponsor
- National Taiwan UniversityCollaborator
- Taipei Veteran General hospitalSponsor investigator
- FBD BiologicsCollaborator
- Taipei Veteran General hospitalOfficial
- Chang Gung UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.